Table 3.
AMH BASELINE | AMH CHANGE1 | Ages 35–39 | Ages 40–44 | Ages 45–48 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
N | Median time2 | 95% CI | N | Median time2 | 95% CI | N | Median time2 | 95% CI | ||
Low <1.0 ng/mL | Fast | 18 | 10.12 | 5.93 – NA3 | 37 | 8.83 | 8.01 – 9.81 | 29 | 7.99 | 6.26 – 8.69 |
Slow | 30 | 12.67 | 10.58 – 12.84 | 37 | 9.47 | 8.61 – 10.26 | 4 | 8.60 | 5.03 – 10.27 | |
High ≥1.0 ng/mL | Fast | 20 | 12.26 | 8.85 – 13.01 | 39 | 10.29 | 9.12 – 11.13 | 3 | 8.00 | 6.23 – NA3 |
Slow | 56 | NA4 | ------ | 20 | 12.76 | 9.40 – NA3 | 0 | NA4 | ------ |
N=293
Rate of change is calculated as the difference between the first undetectable level or the last detectable value of log AMH and log AMH baseline level per year. The rate of AMH change is divided at the sample median; below the median (slow change) is the reference group.
Median time to menopause (yrs) from Kaplan-Meier estimates.
No upper confidence limit due to continuing follow-up.
Estimate uninterpretable due to insufficient number reaching menopause.